- Country: Norway
- Summary: Notice of Intent - Additional Agreement to 2501C, Human Fibrinogen, Thrombin - Atc Code B02b C30
- NOT Ref No: 111813392
- Deadline: 27 Dec 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: NOK 52000000
- Notice Type: Tender
- Document Ref. No.: 2024-117843
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Sykehusinnkj0p HF, pharmaceuticals division obtains offers for pharmaceuticals that are used by healthcare institutions. An open tender, 2501c, has previously been announced and carried out, where the tender included active ingredients in accordance with the competition basis's Appendix 2 Price Schedule.
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINNotice of Intent - Additional Agreement to 2501C, Human Fibrinogen, Thrombin - Atc Code B02b C30 - Norway Tender
The HOSPITAL PURCHASE HF, a Government sector organization in Norway, has announced a new tender for Notice of Intent - Additional Agreement to 2501C, Human Fibrinogen, Thrombin - Atc Code B02b C30. This tender is published on NorwayTenders under NOT Ref No: 111813392 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-12-27.
The estimated tender value is NOK 52000000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
